UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Induction of resident memory T cells enhances the efficacy of cancer vaccine

Nature communications, 2017-05, Vol.8 (1), p.15221-15221, Article 15221

2017

Link zum Volltext

Verfügbarkeit prüfen

Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study

PLoS medicine, 2016-12, Vol.13 (12), p.e1002199-e1002199

2016

Link zum Volltext

Verfügbarkeit prüfen

Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations

PloS one, 2016-07, Vol.11 (7), p.e0159094-e0159094

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for Solid Tumors

Cancers, 2023-03, Vol.15 (6), p.1646

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians

Cancer treatment reviews, 2018-04, Vol.65, p.54-64

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer

BMC cancer, 2022-05, Vol.22 (1), p.529-529, Article 529

2022

Link zum Volltext

Verfügbarkeit prüfen

CXCR6 expressing T cells: Functions and role in the control of tumors

Frontiers in immunology, 2022-10, Vol.13, p.1022136-1022136

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma

Journal of translational medicine, 2023-05, Vol.21 (1), p.324-324, Article 324

2023

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

Cancers, 2017-08, Vol.9 (8), p.101

2017

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review

Orphanet journal of rare diseases, 2013-08, Vol.8 (1), p.127-127, Article 127

2013

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression

Cancers, 2023-11, Vol.15 (23), p.5587

2023

Link zum Volltext

Verfügbarkeit prüfen

CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001948

2021

Link zum Volltext

Verfügbarkeit prüfen

Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma

International journal of cancer, 2013-05, Vol.132 (9), p.2217-2221

2013

Link zum Volltext

Verfügbarkeit prüfen

EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy

Cancers, 2021-10, Vol.13 (20), p.5132

2021

Link zum Volltext

Verfügbarkeit prüfen

High grade neuroendocrine lung tumors: Pathological characteristics, surgical management and prognostic implications

Lung cancer (Amsterdam, Netherlands), 2013-09, Vol.81 (3), p.404-409

2013

Link zum Volltext

Verfügbarkeit prüfen

Retroperitoneal liposarcomas: Follow‐up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas

Cancer, 2006-06, Vol.106 (12), p.2725-2733

2006

Link zum Volltext

Verfügbarkeit prüfen

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer

Pharmaceutics, 2022-09, Vol.14 (9), p.1844

2022

Link zum Volltext

Verfügbarkeit prüfen

TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma

PloS one, 2012-01, Vol.7 (1), p.e29954-e29954

2012

Link zum Volltext

Verfügbarkeit prüfen

Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer

Oncoimmunology, 2019-02, Vol.8 (2), p.e1527498-e1527498

2019

Link zum Volltext

Verfügbarkeit prüfen

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas

Cancer medicine (Malden, MA), 2019-08, Vol.8 (9), p.4330-4337

2019

Link zum Volltext

Verfügbarkeit prüfen

Letter to the editor regarding the paper by Loquai C et al. ‘Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients’

European journal of cancer (1990), 2017-11, Vol.85, p.158-159

2017

Link zum Volltext

Verfügbarkeit prüfen

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2019-12, Vol.20 (12), p.1655-1669

2019

Link zum Volltext

Verfügbarkeit prüfen

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma

BMC medical genomics, 2008-06, Vol.1 (1), p.25-25, Article 25

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Induction of resident memory T cells enhances the efficacy of cancer vaccine

Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study

Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations

Immunotherapy for Solid Tumors

Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer

CXCR6 expressing T cells: Functions and role in the control of tumors

A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review

Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression

CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors

Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma

EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy

High grade neuroendocrine lung tumors: Pathological characteristics, surgical management and prognostic implications

Retroperitoneal liposarcomas: Follow‐up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer

TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma

Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer

Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas

Letter to the editor regarding the paper by Loquai C et al. ‘Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients’

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma

Suchergebnisse filtern